Related Experiment Video
Updated: Jan 6, 2026
10:35
Microvascular Decompression: Salient Surgical Principles and Technical Nuances
Published on: July 5, 2011
47.1K
Clinical Research on Delayed Cure after Microvascular Decompression for Hemifacial Spasm
Ming-Wu Li1, Xiao-Feng Jiang1, Min Wu2,3
1Department of Neurosurgery, The First Affiliated Hospital of University of Science and Technology of China, Anhui Provincial Hospital, Anhui Provincial Stereotactic Neurological Institute, Anhui Provincial Key Laboratory of Brain Function and Disease, Hefei, Anhui, China.
Summary
Delayed cure after microvascular decompression (MVD) for hemifacial spasm (HFS) is linked to disease duration and severity. Consider this delay when assessing treatment outcomes and planning reoperations.
Area of Science:
- Neurosurgery
- Neurology
- Clinical Medicine
Background:
- Hemifacial spasm (HFS) is a neurological disorder characterized by involuntary muscle contractions on one side of the face.
- Microvascular decompression (MVD) is a primary surgical treatment for HFS, aiming to alleviate neurovascular compression.
- Understanding factors influencing treatment outcomes is crucial for optimizing patient care.
Purpose of the Study:
- To statistically analyze clinical data of patients with HFS undergoing MVD.
- To identify specific factors associated with delayed cure following MVD surgery.
- To provide insights for managing patient expectations and treatment strategies.
Main Methods:
- Retrospective analysis of clinical data from 600 HFS patients who underwent MVD.
- Statistical methods included Student t test, chi-square test, logistic regression, and multivariate analysis of variance.
- Correlation between delayed cure and factors like disease course, HFS severity, and intraoperative findings were assessed.
Main Results:
- 117 out of 600 patients experienced delayed cure, averaging 108 days (range: 4-540 days).
- Delayed cure was not associated with sex, age, or offending vessel type (p > 0.05).
- Positive correlations were found between delayed cure and longer disease duration, higher HFS severity grade, and intraoperative disappearance of abnormal muscle responses (p < 0.05).
Conclusions:
- MVD is an effective treatment for HFS, but delayed cure can occur.
- Factors such as disease duration and severity influence the time to recovery.
- Delayed cure should be anticipated in reoperation cases, and efficacy assessments should be timed accordingly.
